ONTOLOGY REPORT - ANNOTATIONS
| Term: | activation of MAPK activity |
|
| Accession: | GO:0000187
|
browse the term
|
| Definition: | The initiation of the activity of the inactive enzyme MAP kinase by phosphorylation by a MAPKK. |
| Synonyms: | exact_synonym: | MAPK activation; activation of MAP kinase |
| | narrow_synonym: | activation of MAPK activity during sporulation |
| | xref_analog: | Reactome:REACT_100881; Reactome:REACT_101870; Reactome:REACT_101978; Reactome:REACT_102664; Reactome:REACT_102813; Reactome:REACT_103235; Reactome:REACT_103251; Reactome:REACT_106101; Reactome:REACT_112664; Reactome:REACT_113767; Reactome:REACT_114778; Reactome:REACT_1482; Reactome:REACT_21399; Reactome:REACT_25355; Reactome:REACT_25370; Reactome:REACT_28684; Reactome:REACT_29727; Reactome:REACT_30502; Reactome:REACT_32301; Reactome:REACT_34590; Reactome:REACT_77440; Reactome:REACT_77987; Reactome:REACT_78017; Reactome:REACT_83894; Reactome:REACT_84937; Reactome:REACT_86273; Reactome:REACT_86655; Reactome:REACT_87442; Reactome:REACT_88492; Reactome:REACT_88606; Reactome:REACT_91962; Reactome:REACT_93371; Reactome:REACT_98123; Reactome:REACT_99633 |
|
|
activation of MAPK activity
|
| G |
Adra2b |
adrenoceptor alpha 2B |
|
|
IMP |
3 |
114,867,357 |
114,869,680 |
RGD:1304238 |
RGD |
| G |
Alk |
anaplastic lymphoma receptor tyrosine kinase |
|
|
IEA |
6 |
23,009,061 |
23,730,939 |
RGD:1600115 |
InterPro |
| G |
Arrb1 |
arrestin, beta 1 |
|
|
IDA |
1 |
156,871,564 |
156,937,540 |
RGD:1304268 |
RGD |
| G |
Arrb1 |
arrestin, beta 1 |
|
|
IDA |
1 |
156,871,564 |
156,937,540 |
RGD:631797 |
RGD |
| G |
Avpi1 |
arginine vasopressin-induced 1 |
|
|
ISO |
1 |
248,727,385 |
248,733,112 |
RGD:1624291 |
RGD |
| G |
Avpi1 |
arginine vasopressin-induced 1 |
|
|
IEA |
1 |
248,727,385 |
248,733,112 |
RGD:1600115 |
ENSEMBL |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
|
ISO |
3 |
121,372,692 |
121,381,236 |
RGD:1624291 |
RGD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
|
ISO |
3 |
121,372,692 |
121,381,236 |
RGD:1624291 |
RGD |
| G |
C1qtnf2 |
C1q and tumor necrosis factor related protein 2 |
|
|
ISO |
10 |
28,571,051 |
28,588,714 |
RGD:1624291 |
RGD |
| G |
C1qtnf2 |
C1q and tumor necrosis factor related protein 2 |
|
|
IEA |
10 |
28,571,051 |
28,588,714 |
RGD:1600115 |
ENSEMBL |
| G |
Cd74 |
Cd74 molecule, major histocompatibility complex, class II invariant chain |
|
|
IDA |
18 |
56,756,511 |
56,765,711 |
RGD:728220 |
RGD |
| G |
Cd81 |
Cd81 molecule |
|
|
ISO |
1 |
203,327,287 |
203,342,901 |
RGD:1624291 |
RGD |
| G |
Cd81 |
Cd81 molecule |
|
|
ISS |
1 |
203,327,287 |
203,342,901 |
RGD:1600115 |
UniProtKB |
| G |
Cd81 |
Cd81 molecule |
|
|
IEA |
1 |
203,327,287 |
203,342,901 |
RGD:1600115 |
ENSEMBL |
| G |
Chrna7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
|
|
ISO |
1 |
117,587,580 |
117,716,267 |
RGD:1624291 |
RGD |
| G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
|
|
ISO |
8 |
60,610,835 |
60,645,877 |
RGD:1624291 |
RGD |
| G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
|
|
IEA |
8 |
60,610,835 |
60,645,877 |
RGD:1600115 |
ENSEMBL |
| G |
Drd4 |
dopamine receptor D4 |
|
|
ISO |
1 |
201,485,597 |
201,488,784 |
RGD:1624291 |
RGD |
| G |
Drd4 |
dopamine receptor D4 |
|
|
ISO |
1 |
201,485,597 |
201,488,784 |
RGD:1624291 |
RGD |
| G |
Drd4 |
dopamine receptor D4 |
|
|
IEA |
1 |
201,485,597 |
201,488,784 |
RGD:1600115 |
ENSEMBL |
| G |
Efna1 |
ephrin A1 |
|
|
ISO |
2 |
181,444,599 |
181,451,944 |
RGD:1624291 |
RGD |
| G |
Efna1 |
ephrin A1 |
|
|
IEA |
2 |
181,444,599 |
181,451,944 |
RGD:1600115 |
ENSEMBL |
| G |
Epgn |
epithelial mitogen |
|
|
ISO |
14 |
18,573,036 |
18,579,934 |
RGD:1624291 |
RGD |
| G |
Fcer1a |
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide |
|
|
ISO |
13 |
89,429,982 |
89,436,507 |
RGD:1624291 |
RGD |
| G |
Fgf10 |
fibroblast growth factor 10 |
|
|
ISO |
2 |
50,866,799 |
50,940,319 |
RGD:1624291 |
RGD |
| G |
Fgf10 |
fibroblast growth factor 10 |
|
|
IEA |
2 |
50,866,799 |
50,940,319 |
RGD:1600115 |
ENSEMBL |
| G |
Frs2 |
fibroblast growth factor receptor substrate 2 |
|
|
ISO |
7 |
56,409,863 |
56,490,535 |
RGD:1624291 |
RGD |
| G |
Frs2 |
fibroblast growth factor receptor substrate 2 |
|
|
ISO |
7 |
56,409,863 |
56,490,535 |
RGD:1624291 |
RGD |
| G |
Frs2 |
fibroblast growth factor receptor substrate 2 |
|
|
ISO |
7 |
56,409,863 |
56,490,535 |
RGD:1624291 |
RGD |
| G |
Frs2 |
fibroblast growth factor receptor substrate 2 |
|
|
IEA |
7 |
56,409,863 |
56,490,535 |
RGD:1600115 |
ENSEMBL |
| G |
Gab1 |
GRB2-associated binding protein 1 |
|
|
ISO |
19 |
28,980,284 |
29,088,877 |
RGD:1624291 |
RGD |
| G |
Ghr |
growth hormone receptor |
|
|
IDA |
2 |
52,496,517 |
52,658,066 |
|
BHF-UCL |
| G |
Ghrl |
ghrelin/obestatin prepropeptide |
|
|
ISO |
4 |
149,622,566 |
149,628,111 |
RGD:1624291 |
RGD |
| G |
Ghrl |
ghrelin/obestatin prepropeptide |
|
|
ISS |
4 |
149,622,566 |
149,628,111 |
RGD:1600115 |
UniProtKB |
| G |
Grm1 |
glutamate receptor, metabotropic 1 |
|
|
ISO |
1 |
5,318,617 |
5,744,593 |
RGD:1624291 |
RGD |
| G |
Grm1 |
glutamate receptor, metabotropic 1 |
|
|
IEA |
1 |
5,318,617 |
5,744,593 |
RGD:1600115 |
ENSEMBL |
| G |
Grm4 |
glutamate receptor, metabotropic 4 |
|
|
ISO |
20 |
5,627,733 |
5,727,274 |
RGD:1624291 |
RGD |
| G |
Grm4 |
glutamate receptor, metabotropic 4 |
|
|
IEA |
20 |
5,627,733 |
5,727,274 |
RGD:1600115 |
ENSEMBL |
| G |
Hgf |
hepatocyte growth factor |
|
|
ISO |
4 |
14,864,357 |
14,932,513 |
RGD:1624291 |
RGD |
| G |
Hgf |
hepatocyte growth factor |
|
|
IEA |
4 |
14,864,357 |
14,932,513 |
RGD:1600115 |
ENSEMBL |
| G |
Ighe |
immunoglobulin heavy chain (epsilon polypeptide) |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:1624291 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
IEA |
3 |
116,964,422 |
116,970,867 |
RGD:1600115 |
ENSEMBL |
| G |
Ins2 |
insulin 2 |
|
|
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:1624291 |
RGD |
| G |
Ins2 |
insulin 2 |
|
|
IEA |
1 |
202,935,548 |
202,936,379 |
RGD:1600115 |
ENSEMBL |
| G |
Insr |
insulin receptor |
|
|
ISO |
12 |
2,934,967 |
3,087,691 |
RGD:1624291 |
RGD |
| G |
Insr |
insulin receptor |
|
|
IEA |
12 |
2,934,967 |
3,087,691 |
RGD:1600115 |
ENSEMBL |
| G |
Iqgap3 |
IQ motif containing GTPase activating protein 3 |
|
|
ISO |
2 |
180,155,679 |
180,198,814 |
RGD:1624291 |
RGD |
| G |
Iqgap3 |
IQ motif containing GTPase activating protein 3 |
|
|
IEA |
2 |
180,155,679 |
180,198,814 |
RGD:1600115 |
ENSEMBL |
| G |
Itga1 |
integrin, alpha 1 |
|
|
IMP |
2 |
47,107,849 |
47,206,261 |
RGD:2302385 |
RGD |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
|
ISO |
14 |
34,906,043 |
34,984,819 |
RGD:1624291 |
RGD |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
|
IEA |
14 |
34,906,043 |
34,984,819 |
RGD:1600115 |
ENSEMBL |
| G |
Lpar1 |
lysophosphatidic acid receptor 1 |
|
|
ISO |
5 |
76,449,470 |
76,571,458 |
RGD:1624291 |
RGD |
| G |
Lpar1 |
lysophosphatidic acid receptor 1 |
|
|
IEA |
5 |
76,449,470 |
76,571,458 |
RGD:1600115 |
ENSEMBL |
| G |
Lpar2 |
lysophosphatidic acid receptor 2 |
|
|
ISO |
16 |
20,079,826 |
20,085,307 |
RGD:1624291 |
RGD |
| G |
Lpar2 |
lysophosphatidic acid receptor 2 |
|
|
IEA |
16 |
20,079,826 |
20,085,307 |
RGD:1600115 |
ENSEMBL |
| G |
Lpar3 |
lysophosphatidic acid receptor 3 |
|
|
ISO |
2 |
244,431,789 |
244,510,815 |
RGD:1624291 |
RGD |
| G |
Lpar3 |
lysophosphatidic acid receptor 3 |
|
|
IEA |
2 |
244,431,789 |
244,510,815 |
RGD:1600115 |
ENSEMBL |
| G |
Lrrk2 |
leucine-rich repeat kinase 2 |
|
|
ISO |
7 |
130,105,902 |
130,267,747 |
RGD:1624291 |
RGD |
| G |
Madd |
MAP-kinase activating death domain |
|
|
ISO |
3 |
75,498,321 |
75,541,073 |
RGD:1624291 |
RGD |
| G |
Madd |
MAP-kinase activating death domain |
|
|
ISO |
3 |
75,498,321 |
75,541,073 |
RGD:1624291 |
RGD |
| G |
Madd |
MAP-kinase activating death domain |
|
|
ISS |
3 |
75,498,321 |
75,541,073 |
RGD:1600115 |
UniProtKB |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
|
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:1624291 |
RGD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
|
IDA |
8 |
68,379,074 |
68,451,554 |
RGD:2293305 |
RGD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
|
TAS |
8 |
68,379,074 |
68,451,554 |
|
UniProtKB |
| G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
|
TAS |
7 |
10,074,654 |
10,094,003 |
|
UniProtKB |
| G |
Map2k3 |
mitogen activated protein kinase kinase 3 |
|
|
ISO |
10 |
47,075,270 |
47,096,617 |
RGD:1624291 |
RGD |
| G |
Map2k3 |
mitogen activated protein kinase kinase 3 |
|
|
ISO |
10 |
47,075,270 |
47,096,617 |
RGD:1624291 |
RGD |
| G |
Map2k5 |
mitogen activated protein kinase kinase 5 |
|
|
IMP |
8 |
67,313,472 |
67,542,723 |
|
BHF-UCL |
| G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
|
|
ISO |
10 |
99,859,684 |
99,974,446 |
RGD:1624291 |
RGD |
| G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
|
|
ISO |
10 |
99,859,684 |
99,974,446 |
RGD:1624291 |
RGD |
| G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
|
|
ISO |
10 |
99,859,684 |
99,974,446 |
RGD:1624291 |
RGD |
| G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
|
|
IEA |
10 |
99,859,684 |
99,974,446 |
RGD:1600115 |
ENSEMBL |
| G |
Map3k11 |
mitogen-activated protein kinase kinase kinase 11 |
|
|
ISO |
1 |
208,312,955 |
208,326,289 |
RGD:1624291 |
RGD |
| G |
Map3k2 |
mitogen activated protein kinase kinase kinase 2 |
|
|
NAS |
18 |
24,606,219 |
24,672,732 |
RGD:724475 |
RGD |
| G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
|
ISO |
1 |
15,205,361 |
15,346,422 |
RGD:1624291 |
RGD |
| G |
Map3k7 |
mitogen activated protein kinase kinase kinase 7 |
|
|
ISO |
5 |
48,252,637 |
48,308,820 |
RGD:1624291 |
RGD |
| G |
Met |
met proto-oncogene |
|
|
ISO |
4 |
43,134,183 |
43,211,355 |
RGD:1624291 |
RGD |
| G |
Met |
met proto-oncogene |
|
|
IEA |
4 |
43,134,183 |
43,211,355 |
RGD:1600115 |
ENSEMBL |
| G |
Muc20 |
mucin 20, cell surface associated |
|
|
ISO |
11 |
69,808,275 |
69,823,526 |
RGD:1624291 |
RGD |
| G |
Muc20 |
mucin 20, cell surface associated |
|
|
IEA |
11 |
69,808,275 |
69,823,526 |
RGD:1600115 |
ENSEMBL |
| G |
Ntf3 |
neurotrophin 3 |
|
|
IEA |
4 |
162,435,781 |
162,506,961 |
RGD:1600115 |
ENSEMBL |
| G |
Ntf3 |
neurotrophin 3 |
|
|
ISO |
4 |
162,435,781 |
162,506,961 |
RGD:1624291 |
RGD |
| G |
Ntrk3 |
neurotrophic tyrosine kinase, receptor, type 3 |
|
|
IEA |
1 |
133,925,530 |
134,302,139 |
RGD:1600115 |
ENSEMBL |
| G |
Ntrk3 |
neurotrophic tyrosine kinase, receptor, type 3 |
|
|
ISO |
1 |
133,925,530 |
134,302,139 |
RGD:1624291 |
RGD |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
|
ISO |
12 |
35,074,025 |
35,117,152 |
RGD:1624291 |
RGD |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
|
IEA |
12 |
35,074,025 |
35,117,152 |
RGD:1600115 |
ENSEMBL |
| G |
Pak3 |
p21 protein (Cdc42/Rac)-activated kinase 3 |
|
|
ISO |
X |
34,734,814 |
34,842,093 |
RGD:1624291 |
RGD |
| G |
Pde6h |
phosphodiesterase 6H, cGMP-specific, cone, gamma |
|
|
ISO |
4 |
174,009,860 |
174,014,405 |
RGD:1624291 |
RGD |
| G |
Pde6h |
phosphodiesterase 6H, cGMP-specific, cone, gamma |
|
|
IEA |
4 |
174,009,860 |
174,014,405 |
RGD:1600115 |
ENSEMBL |
| G |
Plce1 |
phospholipase C, epsilon 1 |
|
|
ISO |
1 |
242,794,858 |
243,103,437 |
RGD:1624291 |
RGD |
| G |
Plce1 |
phospholipase C, epsilon 1 |
|
|
IEA |
1 |
242,794,858 |
243,103,437 |
RGD:1600115 |
ENSEMBL |
| G |
Plce1 |
phospholipase C, epsilon 1 |
|
|
ISS |
1 |
242,794,858 |
243,103,437 |
RGD:1600115 |
UniProtKB |
| G |
Prdx2 |
peroxiredoxin 2 |
|
|
ISO |
19 |
24,836,199 |
24,841,390 |
RGD:1624291 |
RGD |
| G |
Prok1 |
prokineticin 1 |
|
|
ISO |
2 |
202,707,628 |
202,712,886 |
RGD:1624291 |
RGD |
| G |
Prok1 |
prokineticin 1 |
|
|
IEA |
2 |
202,707,628 |
202,712,886 |
RGD:1600115 |
ENSEMBL |
| G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
|
|
ISO |
12 |
36,501,886 |
36,558,055 |
RGD:1624291 |
RGD |
| G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
|
|
ISO |
12 |
36,501,886 |
36,558,055 |
RGD:1624291 |
RGD |
| G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
|
|
IEA |
12 |
36,501,886 |
36,558,055 |
RGD:1600115 |
ENSEMBL |
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
|
ISO |
13 |
51,246,163 |
51,357,995 |
RGD:1624291 |
RGD |
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
|
IEA |
13 |
51,246,163 |
51,357,995 |
RGD:1600115 |
ENSEMBL |
| G |
Pxn |
paxillin |
|
|
ISO |
12 |
42,322,193 |
42,370,507 |
RGD:1624291 |
RGD |
| G |
Pxn |
paxillin |
|
|
IEA |
12 |
42,322,193 |
42,370,507 |
RGD:1600115 |
ENSEMBL |
| G |
Shc1 |
SHC (Src homology 2 domain containing) transforming protein 1 |
|
|
IMP |
2 |
181,616,581 |
181,628,144 |
RGD:1580336 |
RGD |
| G |
Shc1 |
SHC (Src homology 2 domain containing) transforming protein 1 |
|
|
ISO |
2 |
181,616,581 |
181,628,144 |
RGD:1624291 |
RGD |
| G |
Shc1 |
SHC (Src homology 2 domain containing) transforming protein 1 |
|
|
ISO |
2 |
181,616,581 |
181,628,144 |
RGD:1624291 |
RGD |
| G |
Shc1 |
SHC (Src homology 2 domain containing) transforming protein 1 |
|
|
IEA |
2 |
181,616,581 |
181,628,144 |
RGD:1600115 |
ENSEMBL |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
|
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:1624291 |
RGD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
|
ISS |
11 |
29,810,766 |
29,816,342 |
RGD:1600115 |
UniProtKB |
| G |
Spag9 |
sperm associated antigen 9 |
|
|
ISO |
10 |
82,649,289 |
82,762,795 |
RGD:1624291 |
RGD |
| G |
Syk |
spleen tyrosine kinase |
|
|
ISO |
17 |
18,440,672 |
18,498,001 |
RGD:1624291 |
RGD |
| G |
Syk |
spleen tyrosine kinase |
|
|
ISO |
17 |
18,440,672 |
18,498,001 |
RGD:1624291 |
RGD |
| G |
Tdgf1 |
teratocarcinoma-derived growth factor 1 |
|
|
ISO |
8 |
115,341,587 |
115,346,871 |
RGD:1624291 |
RGD |
| G |
Tgfa |
transforming growth factor alpha |
|
|
ISO |
4 |
120,355,649 |
120,437,772 |
RGD:1624291 |
RGD |
| G |
Tgfa |
transforming growth factor alpha |
|
|
ISS |
4 |
120,355,649 |
120,437,772 |
RGD:1600115 |
HGNC |
| G |
Tgfb3 |
transforming growth factor, beta 3 |
|
|
IDA |
6 |
110,173,443 |
110,195,215 |
RGD:1579859 |
RGD |
| G |
Thbs1 |
thrombospondin 1 |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
ISO |
5 |
83,564,100 |
83,577,735 |
RGD:1624291 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
IEA |
5 |
83,564,100 |
83,577,735 |
RGD:1600115 |
ENSEMBL |
| G |
Tnf |
tumor necrosis factor |
|
|
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:1624291 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
|
IEA |
20 |
3,661,000 |
3,663,618 |
RGD:1600115 |
ENSEMBL |
| G |
Tp73 |
tumor protein p73 |
|
|
IMP |
5 |
170,848,979 |
171,078,739 |
RGD:2291838 |
RGD |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
|
ISO |
16 |
3,782,025 |
3,799,625 |
RGD:1624291 |
RGD |
activation of JUN kinase activity
|
| G |
Axin1 |
axin 1 |
|
|
IBA |
10 |
15,409,373 |
15,462,726 |
RGD:1600115 |
RefGenome |
| G |
Crk |
v-crk sarcoma virus CT10 oncogene homolog (avian) |
|
|
TAS |
10 |
63,017,662 |
63,040,420 |
RGD:1298803 |
RGD |
| G |
Dab2 |
disabled 2, mitogen-responsive phosphoprotein |
|
|
ISO |
2 |
55,714,874 |
55,736,370 |
RGD:1624291 |
RGD |
| G |
Dab2ip |
DAB2 interacting protein |
|
|
ISO |
3 |
14,667,700 |
14,840,625 |
RGD:1624291 |
RGD |
| G |
Ercc6 |
excision repair cross-complementing rodent repair deficiency, complementation group 6 |
|
|
ISO |
16 |
8,024,881 |
8,091,587 |
RGD:1624291 |
RGD |
| G |
Ercc6 |
excision repair cross-complementing rodent repair deficiency, complementation group 6 |
|
|
IEA |
16 |
8,024,881 |
8,091,587 |
RGD:1600115 |
ENSEMBL |
| G |
Fcer1a |
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide |
|
|
ISO |
13 |
89,429,982 |
89,436,507 |
RGD:1624291 |
RGD |
| G |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
|
|
IMP |
11 |
86,700,118 |
86,767,928 |
RGD:1299389 |
RGD |
| G |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
|
|
IDA |
11 |
86,700,118 |
86,767,928 |
RGD:1299389 |
MGI |
| G |
Gab1 |
GRB2-associated binding protein 1 |
|
|
ISO |
19 |
28,980,284 |
29,088,877 |
RGD:1624291 |
RGD |
| G |
Gab1 |
GRB2-associated binding protein 1 |
|
|
IEA |
19 |
28,980,284 |
29,088,877 |
RGD:1600115 |
ENSEMBL |
| G |
Ighe |
immunoglobulin heavy chain (epsilon polypeptide) |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Ins2 |
insulin 2 |
|
NOT |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:1624291 |
RGD |
| G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
|
|
IDA |
10 |
52,009,149 |
52,041,599 |
RGD:2298577 |
RGD |
| G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
|
|
IDA |
10 |
52,009,149 |
52,041,599 |
RGD:2298708 |
RGD |
| G |
Map2k7 |
mitogen activated protein kinase kinase 7 |
|
|
IDA |
12 |
1,545,407 |
1,552,353 |
RGD:2298561 |
RGD |
| G |
Map2k7 |
mitogen activated protein kinase kinase 7 |
|
|
IDA |
12 |
1,545,407 |
1,552,353 |
RGD:2298565 |
RGD |
| G |
Map2k7 |
mitogen activated protein kinase kinase 7 |
|
|
IDA |
12 |
1,545,407 |
1,552,353 |
RGD:2298577 |
RGD |
| G |
Map2k7 |
mitogen activated protein kinase kinase 7 |
|
|
ISO |
12 |
1,545,407 |
1,552,353 |
RGD:1624291 |
RGD |
| G |
Map3k1 |
mitogen activated protein kinase kinase kinase 1 |
|
|
ISO |
2 |
43,062,252 |
43,126,058 |
RGD:1624291 |
RGD |
| G |
Map3k1 |
mitogen activated protein kinase kinase kinase 1 |
|
|
ISO |
2 |
43,062,252 |
43,126,058 |
RGD:1624291 |
RGD |
| G |
Map3k11 |
mitogen-activated protein kinase kinase kinase 11 |
|
|
ISO |
1 |
208,312,955 |
208,326,289 |
RGD:1624291 |
RGD |
| G |
Map3k11 |
mitogen-activated protein kinase kinase kinase 11 |
|
|
IEA |
1 |
208,312,955 |
208,326,289 |
RGD:1600115 |
ENSEMBL |
| G |
Map4k2 |
mitogen activated protein kinase kinase kinase kinase 2 |
|
|
ISO |
1 |
209,121,164 |
209,136,316 |
RGD:1624291 |
RGD |
| G |
Map4k2 |
mitogen activated protein kinase kinase kinase kinase 2 |
|
|
IEA |
1 |
209,121,164 |
209,136,316 |
RGD:1600115 |
ENSEMBL |
| G |
Mapk8ip3 |
mitogen-activated protein kinase 8 interacting protein 3 |
|
|
ISO |
10 |
14,147,895 |
14,186,277 |
RGD:1624291 |
RGD |
| G |
Mdfi |
MyoD family inhibitor |
|
|
ISO |
9 |
8,623,038 |
8,641,388 |
RGD:1624291 |
RGD |
| G |
Mdfi |
MyoD family inhibitor |
|
|
IEA |
9 |
8,623,038 |
8,641,388 |
RGD:1600115 |
ENSEMBL |
| G |
Mdfic |
MyoD family inhibitor domain containing |
|
|
IEA |
4 |
41,241,856 |
41,321,515 |
RGD:1600115 |
ENSEMBL |
| G |
Mdfic |
MyoD family inhibitor domain containing |
|
|
ISO |
4 |
41,241,856 |
41,321,515 |
RGD:1624291 |
RGD |
| G |
Mul1 |
mitochondrial E3 ubiquitin protein ligase 1 |
|
|
IEA |
5 |
157,213,350 |
157,222,401 |
RGD:1600115 |
ENSEMBL |
| G |
Mul1 |
mitochondrial E3 ubiquitin protein ligase 1 |
|
|
ISO |
5 |
157,213,350 |
157,222,401 |
RGD:1624291 |
RGD |
| G |
Spag9 |
sperm associated antigen 9 |
|
|
ISO |
10 |
82,649,289 |
82,762,795 |
RGD:1624291 |
RGD |
| G |
Syk |
spleen tyrosine kinase |
|
|
ISO |
17 |
18,440,672 |
18,498,001 |
RGD:1624291 |
RGD |
| G |
Syk |
spleen tyrosine kinase |
|
|
IEA |
17 |
18,440,672 |
18,498,001 |
RGD:1600115 |
ENSEMBL |
| G |
Tf |
transferrin |
|
|
ISO |
8 |
108,217,774 |
108,244,487 |
RGD:1624291 |
RGD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
|
ISO |
15 |
59,397,837 |
59,428,014 |
RGD:1624291 |
RGD |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
|
ISO |
16 |
3,782,025 |
3,799,625 |
RGD:1624291 |
RGD |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
|
ISO |
16 |
3,782,025 |
3,799,625 |
RGD:1624291 |
RGD |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
|
IEA |
16 |
3,782,025 |
3,799,625 |
RGD:1600115 |
ENSEMBL |
| G |
Wnt7b |
wingless-type MMTV integration site family, member 7B |
|
|
IDA |
7 |
123,533,713 |
123,554,333 |
RGD:2292645 |
RGD |
| G |
Zak |
sterile alpha motif and leucine zipper containing kinase AZK |
|
|
ISO |
3 |
54,767,724 |
54,915,022 |
RGD:1624291 |
RGD |
activation of MAPK activity by adrenergic receptor signaling pathway
|
| G |
Adra2a |
adrenoceptor alpha 2A |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Adra2a |
adrenoceptor alpha 2A |
|
|
IEA |
|
|
|
RGD:1600115 |
ENSEMBL |
| G |
Adra2b |
adrenoceptor alpha 2B |
|
|
ISO |
3 |
114,867,357 |
114,869,680 |
RGD:1624291 |
RGD |
| G |
Adra2b |
adrenoceptor alpha 2B |
|
|
IEA |
3 |
114,867,357 |
114,869,680 |
RGD:1600115 |
ENSEMBL |
| G |
Adra2c |
adrenoceptor alpha 2C |
|
|
ISO |
14 |
81,107,907 |
81,109,610 |
RGD:1624291 |
RGD |
| G |
Adra2c |
adrenoceptor alpha 2C |
|
|
IEA |
14 |
81,107,907 |
81,109,610 |
RGD:1600115 |
ENSEMBL |
activation of MAPK activity involved in innate immune response
|
| G |
Adam8 |
ADAM metallopeptidase domain 8 |
|
|
ISO |
1 |
199,780,772 |
199,791,855 |
RGD:1624291 |
RGD |
| G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
|
ISO |
19 |
19,662,337 |
19,697,341 |
RGD:1624291 |
RGD |
Term paths to the root
|